Zealand Pharma A/S (Denmark)'s ticker is and the CUSIP is 999999999. A total of 2 filers reported holding Zealand Pharma A/S (Denmark) in Q2 2014. The put-call ratio across all filers is - and the average weighting 3.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $56,907,000 | -1.2% | 134,268,164 | +5.9% | 7.76% | +6.3% |
Q2 2014 | $57,621,000 | -22.7% | 126,824,020 | -16.1% | 7.30% | -11.5% |
Q1 2014 | $74,497,000 | -11.7% | 151,209,346 | -6.2% | 8.25% | -8.7% |
Q4 2013 | $84,356,000 | +44.6% | 161,282,633 | +18.8% | 9.04% | +26.2% |
Q3 2013 | $58,342,000 | +42.6% | 135,703,328 | -5.2% | 7.16% | +29.8% |
Q2 2013 | $40,916,000 | – | 143,142,401 | – | 5.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MARXE AUSTIN W & GREENHOUSE DAVID M | 135,703,328 | $58,342,000 | 7.16% |
Hirtle Callaghan & Co LLC | 2 | $75,000 | 0.01% |
NORDEA INVESTMENT MANAGEMENT AB | 182,824 | $0 | 0.00% |